StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Cannara Biotech Inc.
TSXV:LOVE.V
Sector
Location
Market Cap
USD 101.01 M
Share Price
USD 1.10
Avg Daily Volume
43,371
Change (1 day)
3.60%
Change (1 year)
Change (YTD)
92.84%
Cannara Biotech Inc. Revenue Per Share for the year ending August 31, 2024: USD 0.67
Cannara Biotech Inc. Revenue Per Share is USD 0.67 for the year ending August 31, 2024, a 41.80% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Cannara Biotech Inc. Revenue Per Share for the year ending August 31, 2023 was USD 0.47, a 52.44% change year over year.
-
Cannara Biotech Inc. Revenue Per Share for the year ending August 31, 2022 was USD 0.31, a 76.49% change year over year.
-
Cannara Biotech Inc. Revenue Per Share for the year ending August 31, 2021 was USD 0.18, a 543.52% change year over year.
-
Cannara Biotech Inc. Revenue Per Share for the year ending August 31, 2020 was USD 0.03, a 23.46% change year over year.
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Loblaw Companies Limited
USD 164.13
L.TO
+2.22
1.37%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.72
600436.SS
-0.04
-0.13%
Yunnan Baiyao Group Co.,Ltd
USD 7.76
000538.SZ
-0.02
-0.31%
AptarGroup, Inc.
USD 161.04
ATR
+0.72
0.45%
Walgreens Boots Alliance, Inc.
USD 11.45
WBA
-0.04
-0.35%
Clicks Group Limited
USD 21.46
CLS.JO
+0.26
1.23%
EBOS Group Limited
USD 23.93
EBO.AX
+0.09
0.39%
Nahdi Medical Company
USD 34.75
4164.SR
+0.53
1.56%
Prestige Consumer Healthcare Inc.
USD 79.98
PBH
-0.20
-0.25%
Ajanta Pharma Limited
USD 30.85
AJANTPHARM.NS
+0.03
0.10%
Rohto Pharmaceutical Co.,Ltd.
USD 14.21
4527.T
-0.03
-0.20%
Jamjoom Pharmaceuticals Factory Company
USD 44.52
4015.SR
-0.69
-1.53%
Gerresheimer AG
USD 57.42
GXI.DE
-0.09
-0.15%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.25%
Dis-Chem Pharmacies Limited
USD 1.89
DCP.JO
+0.06
3.53%
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
The Procter & Gamble Company
USD 160.83
PG
-0.37
-0.23%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Loblaw Companies Limited
USD 164.13
L.TO
+2.22
1.37%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.72
600436.SS
-0.04
-0.13%
Yunnan Baiyao Group Co.,Ltd
USD 7.76
000538.SZ
-0.02
-0.31%
AptarGroup, Inc.
USD 161.04
ATR
+0.72
0.45%
Walgreens Boots Alliance, Inc.
USD 11.45
WBA
-0.04
-0.35%
Clicks Group Limited
USD 21.46
CLS.JO
+0.26
1.23%
EBOS Group Limited
USD 23.93
EBO.AX
+0.09
0.39%
Nahdi Medical Company
USD 34.75
4164.SR
+0.53
1.56%
Prestige Consumer Healthcare Inc.
USD 79.98
PBH
-0.20
-0.25%
Ajanta Pharma Limited
USD 30.85
AJANTPHARM.NS
+0.03
0.10%
Rohto Pharmaceutical Co.,Ltd.
USD 14.21
4527.T
-0.03
-0.20%
Jamjoom Pharmaceuticals Factory Company
USD 44.52
4015.SR
-0.69
-1.53%
Gerresheimer AG
USD 57.42
GXI.DE
-0.09
-0.15%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.25%
Dis-Chem Pharmacies Limited
USD 1.89
DCP.JO
+0.06
3.53%
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
The Procter & Gamble Company
USD 160.83
PG
-0.37
-0.23%